Windtree Therapeutics (NASDAQ:WINT) reported quarterly losses of $(0.46) per share. This is a 4.55 percent decrease over losses of $(0.44) per share from the same period last year.
Related Posts
‘AT&T Stadium among possible Super Bowl LVI replacement venue options’ -Wednesday WFAA Report
https://www.wfaa.com/article/sports/nfl/att-stadium-among-possible-super-bowl-lvi-replacement-venue-options-nfl-confirms-covid-sofi-stadium-california-dallas-cowboys-backup-host-los-angeles/287-a081b355-85e7-40c4-94d7-79
Raymond James Upgrades CubeSmart to Outperform, Announces $60 Price Target
Raymond James analyst Jonathan Hughes upgrades CubeSmart (NYSE:CUBE) from Market Perform to Outperform and announces $60 price target.
How Good Are Porch Group’s Earnings? | Return On Capital Employed
According to Benzinga Pro data, during Q2, Porch Group (NASDAQ:PRCH) posted sales of $51.34 million. Earnings were up 22.57%, but Porch Group still reported an overall loss of $22.94 million.